
Brooks Laboratories Ltd Falls to 52-Week Low of Rs.54.2 Amid Market Downturn
2026-03-19 15:09:19Brooks Laboratories Ltd’s shares declined sharply to a new 52-week low of Rs.54.2 on 19 Mar 2026, marking a significant drop amid broader market weakness and sectoral pressures. The stock underperformed the Pharmaceuticals & Biotechnology sector and the wider market, reflecting ongoing concerns about its long-term performance and valuation metrics.
Read full news article
Brooks Laboratories Ltd Stock Falls to 52-Week Low of Rs.54.62
2026-03-17 13:40:44Brooks Laboratories Ltd has touched a new 52-week low of Rs.54.62 today, marking a significant decline in its stock price amid broader market movements. The stock has underperformed its sector and key benchmarks, reflecting ongoing concerns about its financial metrics and market positioning.
Read full news article
Brooks Laboratories Ltd Falls to 52-Week Low of Rs.57 Amid Continued Downtrend
2026-03-16 10:50:36Brooks Laboratories Ltd has touched a new 52-week low of Rs.57 today, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and performance metrics.
Read full news article
Brooks Laboratories Ltd Stock Falls to 52-Week Low of Rs.57.06
2026-03-13 19:26:38Brooks Laboratories Ltd has reached a new 52-week low of Rs.57.06, marking a significant decline in its stock price amid broader market weakness and sector underperformance. The stock’s recent performance reflects ongoing challenges in its financial metrics and market positioning within the Pharmaceuticals & Biotechnology sector.
Read full news article
Brooks Laboratories Ltd is Rated Sell
2026-03-12 10:10:52Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Brooks Laboratories Ltd Stock Hits 52-Week Low at Rs.57.84
2026-03-09 12:27:11Brooks Laboratories Ltd has reached a new 52-week low of Rs.57.84, marking a significant decline amid broader market weakness and ongoing challenges within the Pharmaceuticals & Biotechnology sector. The stock’s recent performance reflects a continuation of downward momentum, with a three-day losing streak culminating in a 5.27% drop over this period.
Read full news article
Brooks Laboratories Ltd Stock Hits 52-Week Low at Rs.58.25
2026-03-02 11:42:18Brooks Laboratories Ltd has reached a new 52-week low of Rs.58.25 today, marking a significant decline in its share price amid ongoing market pressures and a series of underwhelming performance metrics. The stock’s recent trajectory reflects a challenging period for the company within the Pharmaceuticals & Biotechnology sector.
Read full news article
Brooks Laboratories Ltd is Rated Sell
2026-02-28 10:10:36Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
13-Mar-2026 | Source : BSENewspaper Publication regarding the Special Window open for re-lodgement of transfer deed.
Update On Scheme Of Arrangement Involving Brooks Steriscience Limited (BSL) A Joint Venture / Associate Of The Company.
06-Mar-2026 | Source : BSEWe refer to our intimation dated September 26 2025 regarding update on Scheme of Arrangement involving Brooks Steriscience Limited (BSL) a Joint Venture/Associate of the Company.
Announcement under Regulation 30 (LODR)-Newspaper Publication
07-Feb-2026 | Source : BSENewspaper Publication dated 7th February 2026 of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Brooks Laboratories Ltd has announced 1:16 rights issue, ex-date: 28 Jul 23







